RVSP of WT mice (n = 9) and WT mice treated chronically with t-TUCB (n = 7), a sEH inhibitor, under control conditions and exposure of mice to hypoxia in the absence and presence of 14,15-EEZE respectively. *Significant difference from their controls, P < 0.05. #Significant difference from WT mice under hypoxia, P < 0.05. @Significant difference from sEH-KO mice under hypoxia, P < 0.05.